Invention Grant
- Patent Title: Factor XI antibodies and methods of use
-
Application No.: US15192020Application Date: 2016-06-24
-
Publication No.: US10465011B2Publication Date: 2019-11-05
- Inventor: Jorg Eder , Stefan Ewert , Ulrich Hassiepen , Yasser Khder , Lorenz Mayr , Samu Melkko , Nikolaus Schiering
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/36 ; C07K16/40 ; A61P7/02 ; A61K45/06 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20170022292A1 FACTOR XI ANTIBODIES AND METHODS OF USE Public/Granted day:2017-01-26
Information query
